The role of NF-κB activation during protection against Leishmania infection

International Journal of Medical Microbiology

Volumn 302, Issue 4-5, 2012, Pages 230-235

  Reinhard, Katharina ^a   Huber, Magdalena ^a   Lohoff, Michael ^a   Visekruna, Alexander ^a  

^a PHILIPPS UNIVERSITY MARBURG   (Germany)

Author keywords

Cytokines; Leishmania infection; NF B; Signal transduction; Toll like receptors

Indexed keywords

CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN BINDING PROTEIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 12; TOLL LIKE RECEPTOR; TRANSCRIPTION FACTOR REL; TRANSCRIPTION FACTOR RELA; TRANSFORMING GROWTH FACTOR BETA ACTIVATED KINASE 1; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 6;

ACETYLATION; AMASTIGOTE; ANTIGEN PRESENTING CELL; CD4+ T LYMPHOCYTE; IMMUNOGENICITY; LEISHMANIASIS; LYMPHOCYTE; MACROPHAGE ACTIVATION; NONHUMAN; PARASITE IMMUNITY; PROTEIN BINDING; PROTEIN INDUCTION; PROTEIN PROTEIN INTERACTION; SHORT SURVEY; SIGNAL TRANSDUCTION; TH1 CELL;

ANIMALS; ANTIGEN-PRESENTING CELLS; CYTOKINES; GENE EXPRESSION REGULATION; HUMANS; LEISHMANIA; LEISHMANIASIS; LYMPHOCYTES; MAP KINASE SIGNALING SYSTEM; NF-KAPPA B; PROTEIN TRANSPORT; TOLL-LIKE RECEPTORS; TRANSCRIPTION, GENETIC; TRANSCRIPTIONAL ACTIVATION;

EID: 84866628737     PISSN: 14384221     EISSN: 16180607     Source Type: Journal    
DOI: 10.1016/j.ijmm.2012.07.006     Document Type: Short Survey

References (70)

1. Abu-Dayyeh I., Hassani K., Westra E.R., Mottram J.C., Olivier M. Comparative study of the ability of Leishmania mexicana promastigotes and amastigotes to alter macrophage signaling and functions. Infect. Immun. 2010, 78:2438-2445.
2. Adachi K., Tsutsui H., Kashiwamura S., Seki E., Nakano H., Takeuchi O., Takeda K., Okumura K., Van K.L., Okamura H., Akira S., Nakanishi K. Plasmodium berghei infection in mice induces liver injury by an IL-12- and toll-like receptor/myeloid differentiation factor 88-dependent mechanism. J. Immunol. 2001, 167:5928-5934.
3. Artis D., Shapira S., Mason N., Speirs K.M., Goldschmidt M., Caamano J., Liou H.C., Hunter C.A., Scott P. Differential requirement for NF-kappa B family members in control of helminth infection and intestinal inflammation. J. Immunol. 2002, 169:4481-4487.
4. Baltimore D. NF-kappaB is 25. Nat. Immunol. 2011, 12:683-685.
5. Becker I., Salaiza N., Aguirre M., Delgado J., Carrillo-Carrasco N., Kobeh L.G., Ruiz A., Cervantes R., Torres A.P., Cabrera N., Gonzalez A., Maldonado C., Isibasi A. Leishmania lipophosphoglycan (LPG) activates NK cells through toll-like receptor-2. Mol. Biochem. Parasitol. 2003, 130:65-74.
6. Beg A.A., Sha W.C., Bronson R.T., Ghosh S., Baltimore D. Embryonic lethality and liver degeneration in mice lacking the RelA component of NF-kappa B. Nature 1995, 376:167-170.
7. Beinke S., Deka J., Lang V., Belich M.P., Walker P.A., Howell S., Smerdon S.J., Gamblin S.J., Ley S.C. NF-kappaB1 p105 negatively regulates TPL-2 MEK kinase activity. Mol. Cell Biol. 2003, 23:4739-4752.
8. Beinke S., Ley S.C. Functions of NF-kappaB1 and NF-kappaB2 in immune cell biology. Biochem. J. 2004, 382:393-409.
9. Belich M.P., Salmeron A., Johnston L.H., Ley S.C. TPL-2 kinase regulates the proteolysis of the NF-kappaB-inhibitory protein NF-kappaB1 p105. Nature 1999, 397:363-368.
10. Belkaid Y., Piccirillo C.A., Mendez S., Shevach E.M., Sacks D.L. CD4+CD25+ regulatory T cells control Leishmania major persistence and immunity. Nature 2002, 420:502-507.
11. Belkaid Y., Rouse B.T. Natural regulatory T cells in infectious disease. Nat. Immunol. 2005, 6:353-360.
12. Ben-Othman R., Dellagi K., Guizani-Tabbane L. Leishmania major parasites induced macrophage tolerance: implication of MAPK and NF-kappaB pathways. Mol. Immunol. 2009, 46:3438-3444.
13. Ben-Othman R., Guizani-Tabbane L., Dellagi K. Leishmania initially activates but subsequently down-regulates intracellular mitogen-activated protein kinases and nuclear factor-kappaB signaling in macrophages. Mol. Immunol. 2008, 45:3222-3229.
14. Bonizzi G., Bebien M., Otero D.C., Johnson-Vroom K.E., Cao Y., Vu D., Jegga A.G., Aronow B.J., Ghosh G., Rickert R.C., Karin M. Activation of IKKalpha target genes depends on recognition of specific kappaB binding sites by RelB:p52 dimers. EMBO J. 2004, 23:4202-4210.
15. Bonizzi G., Karin M. The two NF-kappaB activation pathways and their role in innate and adaptive immunity. Trends Immunol. 2004, 25:280-288.
16. Caamano J., Hunter C.A. NF-kappaB family of transcription factors: central regulators of innate and adaptive immune functions. Clin. Microbiol. Rev. 2002, 15:414-429.
17. Calegari-Silva T.C., Pereira R.M., De-Melo L.D., Saraiva E.M., Soares D.C., Bellio M., Lopes U.G. NF-kappaB-mediated repression of iNOS expression in Leishmania amazonensis macrophage infection. Immunol. Lett. 2009, 127:19-26.
18. Campos M.A., Almeida I.C., Takeuchi O., Akira S., Valente E.P., Procopio D.O., Travassos L.R., Smith J.A., Golenbock D.T., Gazzinelli R.T. Activation of Toll-like receptor-2 by glycosylphosphatidylinositol anchors from a protozoan parasite. J. Immunol. 2001, 167:416-423.
19. Chen G., Hardy K., Pagler E., Ma L., Lee S., Gerondakis S., Daley S., Shannon M.F. The NF-kappaB transcription factor c-Rel is required for Th17 effector cell development in experimental autoimmune encephalomyelitis. J. Immunol. 2011, 187:4483-4491.
20. de Veer M.J., Curtis J.M., Baldwin T.M., DiDonato J.A., Sexton A., McConville M.J., Handman E., Schofield L. MyD88 is essential for clearance of Leishmania major: possible role for lipophosphoglycan and Toll-like receptor 2 signaling. Eur. J. Immunol. 2003, 33:2822-2831.
21. Debus A., Glasner J., Rollinghoff M., Gessner A. High levels of susceptibility and T helper 2 response in MyD88-deficient mice infected with Leishmania major are interleukin-4 dependent. Infect. Immun. 2003, 71:7215-7218.
22. Descoteaux A., Matlashewski G., Turco S.J. Inhibition of macrophage protein kinase C-mediated protein phosphorylation by Leishmania donovani lipophosphoglycan. J. Immunol. 1992, 149:3008-3015.
23. Flandin J.F., Chano F., Descoteaux A. RNA interference reveals a role for TLR2 and TLR3 in the recognition of Leishmania donovani promastigotes by interferon-gamma-primed macrophages. Eur. J. Immunol. 2006, 36:411-420.
24. Franzoso G., Carlson L., Poljak L., Shores E.W., Epstein S., Leonardi A., Grinberg A., Tran T., Scharton-Kersten T., Anver M., Love P., Brown K., Siebenlist U. Mice deficient in nuclear factor (NF)-kappa B/p52 present with defects in humoral responses, germinal center reactions, and splenic microarchitecture. J. Exp. Med. 1998, 187:147-159.
25. Gantke T., Sriskantharajah S., Ley S.C. Regulation and function of TPL-2, an IkappaB kinase-regulated MAP kinase kinase kinase. Cell Res. 2011, 21:131-145.
26. Gerondakis S., Grossmann M., Nakamura Y., Pohl T., Grumont R. Genetic approaches in mice to understand Rel/NF-kappaB and IkappaB function: transgenics and knockouts. Oncogene 1999, 18:6888-6895.
27. Gerondakis S., Grumont R., Gugasyan R., Wong L., Isomura I., Ho W., Banerjee A. Unravelling the complexities of the NF-kappaB signalling pathway using mouse knockout and transgenic models. Oncogene 2006, 25:6781-6799.
28. Gerondakis S., Siebenlist U. Roles of the NF-kappaB pathway in lymphocyte development and function. Cold Spring Harb. Perspect. Biol. 2010, 2:a000182.
29. Ghosh S., Karin M. Missing pieces in the NF-kappaB puzzle. Cell 2002, 109(Suppl.):S81-S96.
30. Gilmore T.D., Gerondakis S. The c-Rel transcription factor in development and disease. Genes Cancer 2011, 2:695-711.
31. Grigoriadis G., Zhan Y., Grumont R.J., Metcalf D., Handman E., Cheers C., Gerondakis S. The Rel subunit of NF-kappaB-like transcription factors is a positive and negative regulator of macrophage gene expression: distinct roles for Rel in different macrophage populations. EMBO J. 1996, 15:7099-7107.
32. Grumont R., Hochrein H., O'Keeffe M., Gugasyan R., White C., Caminschi I., Cook W., Gerondakis S. c-Rel regulates interleukin 12 p70 expression in CD8(+) dendritic cells by specifically inducing p35 gene transcription. J. Exp. Med. 2001, 194:1021-1032.
33. Guizani-Tabbane L., Ben-Aissa K., Belghith M., Sassi A., Dellagi K. Leishmania major amastigotes induce p50/c-Rel NF-kappa B transcription factor in human macrophages: involvement in cytokine synthesis. Infect. Immun. 2004, 72:2582-2589.
34. Hayden M.S., Ghosh S. Signaling to NF-kappaB. Genes Dev. 2004, 18:2195-2224.
35. Hoffmann A., Levchenko A., Scott M.L., Baltimore D. The IkappaB-NF-kappaB signaling module: temporal control and selective gene activation. Science 2002, 298:1241-1245.
36. Ishikawa H., Claudio E., Dambach D., Raventos-Suarez C., Ryan C., Bravo R. Chronic inflammation and susceptibility to bacterial infections in mice lacking the polypeptide (p)105 precursor (NF-kappaB1) but expressing p50. J. Exp. Med. 1998, 187:985-996.
37. Isomura I., Palmer S., Grumont R.J., Bunting K., Hoyne G., Wilkinson N., Banerjee A., Proietto A., Gugasyan R., Li W., McNally A., Steptoe R.J., Thomas R., Shannon M.F., Gerondakis S. c-Rel is required for the development of thymic Foxp3+ CD4 regulatory T cells. J. Exp. Med. 2009.
38. Kollet J.I., Petro T.M. IRF-1 and NF-kappaB p50/cRel bind to distinct regions of the proximal murine IL-12 p35 promoter during costimulation with IFN-gamma and LPS. Mol. Immunol. 2006, 43:623-633.
39. Kontgen F., Grumont R.J., Strasser A., Metcalf D., Li R., Tarlinton D., Gerondakis S. Mice lacking the c-rel proto-oncogene exhibit defects in lymphocyte proliferation, humoral immunity, and interleukin-2 expression. Genes Dev. 1995, 9:1965-1977.
40. Kropf P., Freudenberg M.A., Modolell M., Price H.P., Herath S., Antoniazi S., Galanos C., Smith D.F., Muller I. Toll-like receptor 4 contributes to efficient control of infection with the protozoan parasite Leishmania major. Infect. Immun. 2004, 72:1920-1928.
41. Locksley R.M., Heinzel F.P., Sadick M.D., Holaday B.J., Gardner K.D. Murine cutaneous leishmaniasis: susceptibility correlates with differential expansion of helper T-cell subsets. Ann. Inst. Pasteur. Immunol. 1987, 138:744-749.
42. Lohoff M., Ferrick D., Mittrucker H.W., Duncan G.S., Bischof S., Rollinghoff M., Mak T.W. Interferon regulatory factor-1 is required for a T helper 1 immune response in vivo. Immunity 1997, 6:681-689.
43. Lopez K.S., Dinges S., Griewank K., Iwakura Y., Udey M.C., von Stebut E. IL-17 promotes progression of cutaneous leishmaniasis in susceptible mice. J. Immunol. 2009, 182:3039-3046.
44. Marsland B.J., Kopf M. T-cell fate and function: PKC-theta and beyond. Trends Immunol. 2008, 29:179-185.
45. Mise-Omata S., Kuroda E., Niikura J., Yamashita U., Obata Y., Doi T.S. A proximal kappaB site in the IL-23 p19 promoter is responsible for RelA- and c-Rel-dependent transcription. J. Immunol. 2007, 179:6596-6603.
46. Mise-Omata S., Kuroda E., Sugiura T., Yamashita U., Obata Y., Doi T.S. The NF-kappaB RelA subunit confers resistance to Leishmania major by inducing nitric oxide synthase 2 and Fas expression but not Th1 differentiation. J. Immunol. 2009, 182:4910-4916.
47. Morris L., Troutt A.B., McLeod K.S., Kelso A., Handman E., Aebischer T. Interleukin-4 but not gamma interferon production correlates with the severity of murine cutaneous leishmaniasis. Infect. Immun. 1993, 61:3459-3465.
48. Nandan D., Reiner N.E. Attenuation of gamma interferon-induced tyrosine phosphorylation in mononuclear phagocytes infected with Leishmania donovani: selective inhibition of signaling through Janus kinases and Stat1. Infect. Immun. 1995, 63:4495-4500.
49. Neves B.M., Silvestre R., Resende M., Ouaissi A., Cunha J., Tavares J., Loureiro I., Santarem N., Silva A.M., Lopes M.C., Cruz M.T., Cordeiro da S.A. Activation of phosphatidylinositol 3-kinase/Akt and impairment of nuclear factor-kappaB: molecular mechanisms behind the arrested maturation/activation state of Leishmania infantum-infected dendritic cells. Am. J. Pathol. 2010, 177:2898-2911.
50. Ng L.G., Hsu A., Mandell M.A., Roediger B., Hoeller C., Mrass P., Iparraguirre A., Cavanagh L.L., Triccas J.A., Beverley S.M., Scott P., Weninger W. Migratory dermal dendritic cells act as rapid sensors of protozoan parasites. PLoS Pathog. 2008, 4:e1000222.
51. Oeckinghaus A., Hayden M.S., Ghosh S. Crosstalk in NF-kappaB signaling pathways. Nat. Immunol. 2011, 12:695-708.
52. Pasparakis M. Regulation of tissue homeostasis by NF-kappaB signalling: implications for inflammatory diseases. Nat. Rev. Immunol. 2009, 9:778-788.
53. Peters N., Sacks D. Immune privilege in sites of chronic infection: Leishmania and regulatory T cells. Immunol. Rev. 2006, 213:159-179.
54. Reinhard K., Huber M., Wostl C., Hellhund A., Toboldt A., Abass E., Casper B., Joeris T., Herr C., Bals R., Steinhoff U., Lohoff M., Visekruna A. c-Rel promotes type 1 and type 17 immune responses during Leishmania major infection. Eur. J. Immunol. 2011, 41:1388-1398.
55. Ruan Q., Kameswaran V., Zhang Y., Zheng S., Sun J., Wang J., DeVirgiliis J., Liou H.C., Beg A.A., Chen Y.H. The Th17 immune response is controlled by the Rel-RORgamma-RORgamma T transcriptional axis. J. Exp. Med. 2011, 208:2321-2333.
56. Sanjabi S., Hoffmann A., Liou H.C., Baltimore D., Smale S.T. Selective requirement for c-Rel during IL-12 P40 gene induction in macrophages. Proc. Natl. Acad. Sci. U.S.A. 2000, 97:12705-12710.
57. Santoro M.G., Rossi A., Amici C. NF-kappaB and virus infection: who controls whom. EMBO J. 2003, 22:2552-2560.
58. Scanga C.A., Aliberti J., Jankovic D., Tilloy F., Bennouna S., Denkers E.Y., Medzhitov R., Sher A. Cutting edge: MyD88 is required for resistance to Toxoplasma gondii infection and regulates parasite-induced IL-12 production by dendritic cells. J. Immunol. 2002, 168:5997-6001.
59. Schleicher U., Liese J., Knippertz I., Kurzmann C., Hesse A., Heit A., Fischer J.A., Weiss S., Kalinke U., Kunz S., Bogdan C. NK cell activation in visceral leishmaniasis requires TLR9, myeloid DCs, and IL-12, but is independent of plasmacytoid DCs. J. Exp. Med. 2007, 204:893-906.
60. Sen R., Baltimore D. Multiple nuclear factors interact with the immunoglobulin enhancer sequences. Cell 1986, 46:705-716.
61. Senftleben U., Cao Y., Xiao G., Greten F.R., Krahn G., Bonizzi G., Chen Y., Hu Y., Fong A., Sun S.C., Karin M. Activation by IKKalpha of a second, evolutionary conserved, NF-kappa B signaling pathway. Science 2001, 293:1495-1499.
62. Shapira S., Harb O.S., Caamano J., Hunter C.A. The NF-kappaB signaling pathway: immune evasion and immunoregulation during toxoplasmosis. Int. J. Parasitol. 2004, 34:393-400.
63. Shapira S., Speirs K., Gerstein A., Caamano J., Hunter C.A. Suppression of NF-kappaB activation by infection with Toxoplasma gondii. J. Infect. Dis. 2002, 185(Suppl. 1):S66-S72.
64. Speirs K., Caamano J., Goldschmidt M.H., Hunter C.A., Scott P. NF-kappa B2 is required for optimal CD40-induced IL-12 production but dispensable for Th1 cell differentiation. J. Immunol. 2002, 168:4406-4413.
65. Stenger S., Thuring H., Rollinghoff M., Bogdan C. Tissue expression of inducible nitric oxide synthase is closely associated with resistance to Leishmania major. J. Exp. Med. 1994, 180:783-793.
66. Su T.T., Guo B., Kawakami Y., Sommer K., Chae K., Humphries L.A., Kato R.M., Kang S., Patrone L., Wall R., Teitell M., Leitges M., Kawakami T., Rawlings D.J. PKC-beta controls I kappa B kinase lipid raft recruitment and activation in response to BCR signaling. Nat. Immunol. 2002, 3:780-786.
67. Sun S.C., Ley S.C. New insights into NF-kappaB regulation and function. Trends Immunol. 2008, 29:469-478.
68. Vallabhapurapu S., Karin M. Regulation and function of NF-kappaB transcription factors in the immune system. Annu. Rev. Immunol. 2009, 27:693-733.
69. Visekruna A., Huber M., Hellhund A., Bothur E., Reinhard K., Bollig N., Schmidt N., Joeris T., Lohoff M., Steinhoff U. c-Rel is crucial for the induction of Foxp3(+) regulatory CD4(+) T cells but not T(H)17 cells. Eur. J. Immunol. 2010, 40:671-676.
70. Wang J., Wang X., Hussain S., Zheng Y., Sanjabi S., Ouaaz F., Beg A.A. Distinct roles of different NF-kappa B subunits in regulating inflammatory and T cell stimulatory gene expression in dendritic cells. J. Immunol. 2007, 178:6777-6788.